Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Protalix BioTherapeutics (PLX) Cost of Revenue (2016 - 2025)

Protalix BioTherapeutics has reported Cost of Revenue over the past 16 years, most recently at $4.6 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $4.6 million for Q4 2025, up 18.86% from a year ago — trailing twelve months through Dec 2025 was $27.0 million (up 11.0% YoY), and the annual figure for FY2025 was $27.0 million, up 11.0%.
  • Cost of Revenue for Q4 2025 was $4.6 million at Protalix BioTherapeutics, down from $8.3 million in the prior quarter.
  • Over the last five years, Cost of Revenue for PLX hit a ceiling of $9.5 million in Q2 2024 and a floor of $2.4 million in Q4 2022.
  • Median Cost of Revenue over the past 5 years was $4.8 million (2021), compared with a mean of $5.5 million.
  • Biggest five-year swings in Cost of Revenue: soared 269.46% in 2023 and later tumbled 56.12% in 2024.
  • Protalix BioTherapeutics' Cost of Revenue stood at $3.1 million in 2021, then decreased by 23.86% to $2.4 million in 2022, then soared by 269.46% to $8.9 million in 2023, then tumbled by 56.12% to $3.9 million in 2024, then grew by 18.86% to $4.6 million in 2025.
  • The last three reported values for Cost of Revenue were $4.6 million (Q4 2025), $8.3 million (Q3 2025), and $5.9 million (Q2 2025) per Business Quant data.